On this page
My Way
levonorgestrel · Tablet
Overview
Active ingredients
Source: NDC Directory| Ingredient | Strength | RxCUI | Monograph |
|---|---|---|---|
| Levonorgestrel | 1.5 mg/1 | 483325 | View |
Forms, strengths and routes
Source: NDC DirectoryPharmacologic classes are listed in the class section below.
Pharmacologic class
Source: NDC Directory| Class | Type | Browse |
|---|---|---|
| Inhibit Ovum Fertilization [PE] | PE | All 12 members |
| Progesterone Congeners [CS] | CS | All 40 members |
| Progestin [EPC] | EPC | All 40 members |
| Progestin-containing Intrauterine Device [EPC] | EPC | 7 members — no class page |
| Progestin-containing Intrauterine System [EPC] | EPC | 8 members — no class page |
Regulatory status
Source: Drugs@FDANDC Directory| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 201446-001 | FALLBACK SOLO | TABLET | LEVONORGESTREL | Over-the-counter | — |
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Supplement | 9 | Labeling | Approved | May 1, 2026 | Standard |
| Supplement | 6 | Labeling | Approved | May 1, 2026 | Standard |
| Supplement | 3 | Labeling | Approved | May 1, 2026 | Standard |
| Supplement | 2 | Labeling | Approved | May 13, 2016 | Standard |
| Original application | 1 | Not Applicable | Approved | June 19, 2014 | — |
Prescribing information
Source: openFDA Drug LabelingReproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20250101). This is the manufacturer's labelling text, not a summary and not advice.
Indications and Usage
openFDA Drug LabelingIndications Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control).
Purpose
openFDA Drug LabelingPurpose Emergency contraceptive
Dosage and Administration
openFDA Drug LabelingWhen should I use My Way? The sooner you take emergency contraception, the better it works. You should use My Way within 72 hours (3 days) after you have had unprotected sex . My Way is a backup or emergency method of birth control you can use when: • your regular birth control was used incorrectly or failed • you did not use any birth control method When not to use My Way? My Way should not be used: • as a regular birth control method, because it's not as effective as regular birth control. • if you are already pregnant, because it will not work. • if you are allergic to levonorgestrel or any other ingredients in My Way. When should I talk to a doctor or pharmacist? Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of My Way and increase your chance of becoming pregnant. Your doctor may prescribe another form of emergency contraception that may not be affected by these medications. How does My Way work? My Way is one tablet with levonorgestrel, a hormone that has been used in many birth control pills for several decades. My Way contains a higher dose of levonorgestrel than birth control pills, but works in a similar way to prevent pregnancy. It works mainly by stopping the release of an egg from the ovary. It is possible that My Way may also work by preventing fertilization of an egg (the uniting of sperm with the egg) or by preventing attachment (implantation) to the uterus (womb). How can I get the best results from My Way? You have 72 hours (3 days) to try to prevent pregnancy after birth control failure or unprotected sex. The sooner you take My Way, the better it works . How effective is My Way? If My Way is taken as directed, it can significantly decrease the chance that you will get pregnant. About 7 out of every 8 women who would have gotten pregnant will not become pregnant. How will I know My Way worked? You will know My Way has been effective when you get your next period, which should come at the expected time, or within a week of the expected time. If your period is delayed beyond 1 week, it is possible you may be pregnant. You should get a pregnancy test and follow up with your healthcare professional. Will I experience any side effects? • some women may have changes in their period, such as a period that is heavier or lighter or a period that is early or late. If your period is more than a week late, you may be pregnant. • If you have severe abdominal pain, you may have an ectopic pregnancy, and should get immediate medical attention. • when used as directed, My Way is safe and effective. Side effects may include changes in your period, nausea, lower stomach (abdominal) pain, tiredness, headache, dizziness, and breast tenderness. • if you vomit within 2 hours of taking the medication, call a healthcare professional to find out if you should repeat the dose. What if I still have questions about My Way? If you have questions or need more information, call at 1-800-422-8689 M-F 8:00 am - 5:00 pm or visit our website at www.mywaypill.com. Other Information Keep this and all medication out of reach of children: In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222. Do not use if the seal is opened. Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Active Ingredient: levonorgestrel 1.5 mg Inactive Ingredients: colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, and povidone. My Way ® is a registered trademark of Lupin Pharmaceuticals, Inc. Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 United States Manufactured by: Lupin Limited Pithampur (M.P.) - 454 775 INDIA Relabeled by: Proficient Rx LP Thousand Oaks, CA 91320 Revised: October 2017 ID#: 253401 If you are sexually active, you should see a healthcare provide …
Warnings
openFDA Drug LabelingWarnings Allergy alert: Do not use if you have ever had an allergic reaction to levonorgestrel. Sexually transmitted diseases (STDs) alert: This product does not protect against HIV/AIDS or other STDs Do not use • if you are already pregnant (because it will not work) • for regular birth control Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of levonorgestrel. When using this product you may have • menstrual changes • nausea • lower stomach (abdominal) pain • tiredness • headache • dizziness • breast pain • vomiting
Do Not Use
openFDA Drug LabelingDo not use if you are already pregnant (because it will not work) for regular birth control
Active Ingredient
openFDA Drug LabelingActive Ingredient Levonorgestrel USP 1.5 mg
Adverse event reports
Source: openFDA FAERSAttributed to this product's most-reported active ingredient: LEVONORGESTREL. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 68180-852-11 | 68180-852 | Lupin Pharmaceuticals, Inc. | 1 BLISTER PACK in 1 CARTON (68180-852-11) / 1 TABLET in 1 BLISTER PACK | April 25, 2017 |
| 43386-622-30 | 43386-622 | Lupin Pharmaceuticals,Inc. | 1 TABLET in 1 CARTON (43386-622-30) | February 15, 2013 |
| 68071-4294-1 | 68071-4294 | NuCare Pharmaceuticals,Inc. | 1 TABLET in 1 BOX (68071-4294-1) | February 19, 2018 |
| 71205-361-01 | 71205-361 | Proficient Rx LP | 1 BLISTER PACK in 1 CARTON (71205-361-01) / 1 TABLET in 1 BLISTER PACK | November 18, 2019 |
| 68180-852 | 68180-852 | Lupin Pharmaceuticals, Inc. | — | April 25, 2017 |
| 43386-622 | 43386-622 | Lupin Pharmaceuticals,Inc. | — | February 15, 2013 |
| 68071-4294 | 68071-4294 | NuCare Pharmaceuticals,Inc. | — | April 25, 2017 |
| 71205-361 | 71205-361 | Proficient Rx LP | — | April 25, 2017 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| Drug Labeling | FDA / NLM | Prescribing information reproduced above |
| FAERS | FDA | Adverse event report counts |
Generated September 25, 2026 · 10 sections on this page.